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The  bovine  papillomavirus  (BPV)  is  the  etiological  agent  of  bovine  papillomatosis,  which  causes  signiﬁcant
economic  losses  to livestock,  characterized  by  the  presence  of papillomas  that  regress  spontaneously  or
persist  and  progress  to  malignancy.  Currently,  there  are  13  types  of  BPVs  described  in  the  literature  as well
as  32  putative  new  types.  This study  aimed  to isolate  viral  particles  of BPV  from  skin  papillomas,  using
a novel  viral  isolation  method.  The  virus  types  were  previously  identiﬁed  with  new  primers  designed.
77  cutaneous  papilloma  samples  of 27  animals,  Simmental  breed,  were  surgically  removed.  The  DNA
was extracted  and  subjected  to PCR  using  Delta-Epsilon  and  Xi  primers.  The  bands  were puriﬁed  andiagnosis
irus isolation
ltracentrifugation
sequenced.  The  sequences  were  analyzed  using  software  and  compared  to  the  GenBank  database,  by
BLAST  tool.  The  viral  typing  showed  a prevalence  of BPV-2  in 81.81%  of samples.  It was  also  detected
the  presence  of  the  putative  new  virus  type  BR/UEL2  in  one  sample.  Virus  isolation  was  performed  by
ultracentrifugation  in a single  density  of cesium  chloride.  The  method  of  virus  isolation  is less  laborious
than  those  previously  described,  allowing  the  isolation  of  complete  virus  particles  of  BPV-2.
©  2014  Elsevier  B.V.  All  rights  reserved.Papillomaviruses are oncogenic viruses with double-stranded
ircular DNA genome, not coiled, approximately 8 kb long with
 55–60 nm diameter. The group is included in the Papillomaviri-
ae family, which displays tropism for squamous epithelial and
ucous tissues. These viruses affect vertebrates, including human
Alberti et al., 2010), associated with benign and malignant epithe-
ial lesions (Stocco dos Santos et al., 1998; Roperto et al., 2008;
arvalho et al., 2013).
According to the International Committee on Virus Taxon-
my  (http://ictvonline.org/virusTaxonomy.asp), papillomaviruses
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166-0934/© 2014 Elsevier B.V. All rights reserved.are classiﬁed into 30 genera in accordance with the diversity of
nucleotide sequences of the L1 Open Reading Frame (ORF). Over
10% differences between two  DNA sequences of the L1 ORF deﬁne
a new virus type, while differences between 2 and 10% deﬁne a new
viral subtype (De Villiers et al., 2004).
Speciﬁcally in bovines, currently, there are 13 types of Bovine
Papillomaviruses (BPV) described in the literature, although this
number may  be greater than 20 (Lunardi et al., 2013). BPV types
are classiﬁed into three genera, based on homology to the genomic
regions of the L1 ORF, the most conserved sequence (De Villiers
et al., 2004; De Villiers, 2013): Deltapapillomavirus (BPV-1, 2 and
13), Epsilonpapillomavirus (BPV-5 and 8) Xipapillomavirus (BPV-3,
4, 6, 9, 10, 11 and 12) and BPV-7 that remains not included in any
genre (Araldi et al., 2013).
The BPV icosahedral capsid has 360 copies of the L1 protein of
55 kDa, organized in 72 capsomers and approximately 12 copies of
the L2 protein with 39 kDa (Campo, 1997; Góes et al., 2008; Meinke
and Meinke, 1981) having a molecular weight of 5.2 × 106 Da  (Orth
et al., 1977). The BPV genome is divided into three regions: early,
late and long control, separated by two polyadenylation sites
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Zheng and Baker, 2006) and the viral DNA is associated with
istone-like proteins (Leto et al., 2011). The early control region
ECR) occupies 50% of the viral genome and encodes the proteins
1, E2, E4, E5, E6 and E7. The late control region (LCR) occupies 40%
f the genome and encodes the L1 and L2 proteins. The not cod-
ng region (NCR) occupies 10% of the genome, with approximately
50 bp and, although it is not coding, it contains the origin of repli-
ation (ori) and the binding sites for multiple transcription factors,
mportant for the regulation of RNA polymerase II (Hatama et al.,
008; Zheng and Baker, 2006).
The Bovine papillomavirus (BPV) is the etiologic agent of bovine
apillomatosis, an infectious disease, clinically characterized by the
resence of hyperproliferative lesions (papillomas), causing signif-
cant economic losses to the livestock (Carvalho et al., 2003, 2013).
he infection can result in obstruction of the teat, hindering the
ygiene, mastitis, bleeding of teats and difﬁculty in placing the
echanical milking. Other than that, it is associated with economic
epreciation of animal leather (Catroxo et al., 2013). The virus also
an cause bladder and gastrointestinal cancer in bovines and its
resence has been detected in peripheral blood (Stocco dos Santos
t al., 1998; Freitas et al., 2003; Araldi et al., 2013; Campos et al.,
013). The BPV can also cause sarcoids in equines (Martens et al.,
000; Wobeser et al., 2012). Although considered specie-speciﬁc,
PV-1 and 2 can affect yaks (Bam et al., 2013), tapirs (Kidney and
errocal, 2008), zebras, giraffes, antelopes (Van Dyk et al., 2011);
uffaloes (Pangty et al., 2010) and horses (Chambers et al., 2003)
The BPV infection begins in a micro-tissue lesion, which exposes
he peptydoglicans of heparan sulfate (Hartl et al., 2011; McBride
t al., 2012). The BPV binds to heparan sulfate in cytoplasmatic
embrane of the epithelium cell from the basal layer. In this
rocess the virus particles are internalized through endocytosis,
ediated by clathrin (Hartl et al., 2011; McBride et al., 2012).
After cell infection, BPV reproductive cycle occurs through: (1)
he formation of low-copy viral genome, (2) the maintenance of
eplication and (3) ampliﬁcation of differentiated vegetative cells
McBride et al., 2012). So, the reproductive virus cycle depends of
pithelial cell differentiation, which justiﬁes the absence of a sys-
em for in vitro replication (Shafti-keramat et al., 2003; De Villiers,
013).
Considering the huge size of the national cattle herd and the
igniﬁcant economic losses due to BPV related diseases, the devel-
pment of vaccine strategies is very relevant (Mazzuchelli-Souza
t al., 2013).
Puriﬁcation of virions is essential to obtain information about
irus chemical, physical, biochemical and biological properties and
o reach the production of antiserum (Ali and Roossinck, 2007).
The greatest difﬁculties in vaccine strategies against papil-
omavirus (PV) is the viral isolation of a particular viral type
Kirnbauer et al., 1996), since the co-infection is frequently
bserved (Lindsey et al., 2009; Araldi et al., 2013). However, as far as
e concerned, there is no in vitro PV replication system described
Kirnbauer et al., 1996), and PV is not cultivable (Favre et al., 1974).
There are several methods for BPV isolation described in the lit-
rature, all based on ultracentrifugation in cesium chloride (CsCl)
radients (Bujard, 1967; Larsen et al., 1987; Löhrdr et al., 2005)
r sucrose gradients (Favre, 1975; Liu et al., 1997). However, the
ublished methods to date are laborious and involve complicated
rocedures to obtain sufﬁcient amounts of virions after ultracen-
rifugation (Bujard, 1967; Wang et al., 2007).
This study shows a novel method for the isolation of BPV
irions involving ultracentrifugation, which allows isolate viral par-
icles from monoviral cutaneous papillomas samples. The method
roposed in this work can be used for isolation of other Papillo-
aviruses, including the Human papillomavirus (HPV).
77 samples were collected of cutaneous papillomas from 27
dult bovines (Bos taurus)  at an experimental farm. Surgicall Methods 208 (2014) 119–124
procedures were performed by a veterinarian, using aseptic meth-
ods, local anesthesia (2% lidocaine), incision with sterile bistouries,
and sutured with synthetic 3.0 mononylon. The protocol was
approved by the Ethic Committee on Animal Use. The samples
were transported in coolers at 4 ◦C and a fragment of approximately
25 mg  of each sample were destined to molecular type identiﬁca-
tion.
The DNA extraction was performed using the PureLinkTM
Genomic DNA kit (Invitrogen, Carlsbad, USA) according to the man-
ufacturer instruction, using 25 mg  of tissue. The extracted DNA was
quantiﬁed in spectrophotometer BioPhotometer Plus (Eppendorf,
Hamburg, Germany). It was also determined the ratio A260/A280
and A260/A230 to evaluate the DNA extraction quality.
The DNA quality was  veriﬁed through PCR, using the primer for
bovine -globin (forward 5′-AACCTCTTTGTTCACAAAGAG-3′ and
reverse 5′-CAGATGCTTAACCCACTGAGC-3′), according to Yaguiu
et al. (2008), using 200 ng/l of DNA template. Reactions were per-
formed in the thermocycler Veriti 96 Well Thermal Cycler (Applied
Biosystems, Carlsbad, USA) and subjected to the following cycles:
an initial step of 3 min  at 94 ◦C, 35 cycles with 50 s at 94 ◦C (dena-
turation), 60 s at 60 ◦C (annealing) and 60 s at 72 ◦C (extension) and
a ﬁnal step of 5 min  at 72 ◦C.
The amplicons were analyzed in 2% agarose gel in TAE buffer,
stained with 2.0 l of GelRedTM (Biotium, Hayward, USA)/100 ml
of agarose solution. The electrophoretic run was performed at
100 V, 400 mA for 120 min, with the 100 bp DNA ladder marker
(Invitrogen, Carlsbad, USA). The gel was visualized under transillu-
minator MiniBIS Pro (DNR Bio-Imaging Systems, Jerusalem, Israel)
and images were captured using the software GelCapture 7.1 (DNR
Bio-Imaging Systems, Jerusalem, Israel).
The viral identiﬁcation was  performed using a pair of
degenerated primers Delta-Epsilon (forward 5′-CCAGAYT-
AYYTMAAAATGGC-3′ and reverse 5′-ATAAMKGCTAGCTTATATTC-
3′) and Xi (forward 5′-TWYAATAGDCCVTTTTGGAT-3′ and reverse
5′-TTMCGCCTACGCTTTGGCGC-3′), originally designed based on
homology of sequences of BPVs, allowing to detect BPVs of genera
Delta, Epsilonpapillomavirus (Delta-Epsilon) and Xipapillomavirus
(Xi). These primers amplify the L1 ORF, resulting in products with
430 bp and 600 bp, respectively. These primer pairs were ﬁrstly
designed by Maeda et al. (2007), that named them as subAup
(Delta-Epsilon) and subAdw (Xi)  and subsequently modiﬁed by us.
In order to employ then in the identiﬁcation of BPV in accordance
to viral genres, the ninth base of the subAdw forward primer (G)
was substituted by D, and the twelfth base of this same primer
(C), by V. These chances result in the Xi primer. Thus, changes in
the original PCR cycle were done to optimize these primers to BPV
genres identiﬁcation.
To test the speciﬁcity of both primers to detect BPV accord-
ing to the genera, they were ﬁrstly tested in cloned genomes of
BPV-1 (AB626705), BPV-2 (M20219.1), BPV-3 (AF486184.1), BPV-4
(X05817.1), BPV-5 (NC004195.1) and BPV-6 (AB845589.1).
PCR parameters: reactions were performed in a total volume of
50.0 l, using: 200 ng/l of DNA template. Reactions were done on
the thermocycler Veriti 96 Well Thermal Cycler (Applied Biosys-
tems, Carlsbad, USA), and subjected to the following cycles: an
initial step of 10 min  at 94 ◦C, 35 cycles with 60 s at 94 ◦C (dena-
turation), 60 s at 52 ◦C (annealing), 60 s at 72 ◦C (extension) and
10 min  at 72 ◦C (ﬁnal step). The amplicons were analyzed in pre-
viously described conditions, with positive and negative controls.
As positive control, BPV2 viral genome for Delta-Epsilon primer and
BPV-3 for Xi primer, previously cloned in bacterial vector pAT153
in Escherichia coli D5H strain were selected.The amplicon bands were puriﬁed using the PureLinkTM Quick
Gel Extraction Kit (Invitrogen, Carlsbad, USA), according to the
manufacturer instructions and, after eluted, the material was stored
at −20 ◦C. The sequencing reactions were done on ABI PRISM
R.P. Araldi et al. / Journal of Virological Methods 208 (2014) 119–124 121
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breaks of the disease.ig. 1. Electrophoresis gel: 430 bp amplicons obtained with primer pair Delta-Epsil
omavirus (BPV-5) and 600 bp amplicons obtained with primer pair Xi in detect BPV
730 DNA AnalyzerTM (Applied Biosystems, Carlsbad, USA), using
he BigDye® Terminator v3.1 (Applied Biosystems, Carlsbad, EUA),
mploying 2.5 l of the respective primer at 5 pM.
The quality of the DNA sequences were checked and overlapping
ragments were mounted using the bioinformatics software BioEdit
ersion 7.0.9.0 (Ibis Therapeutics, Carlsbad, USA) and the sequences
ere compared using the NCBI database, through the BLAST tool
http://blast.ncbi.nlm.gov).
After the molecular identiﬁcation of BPV types, 40 g of papilloma
amples with only one viral type were mechanically macerated for
wo minutes with 320 ml  of lyses buffer (1 M NaCl, 0.02 M PBS pH
.0). The product was transferred to cellulose nitrate tubes and
as centrifuged for 30 min  at 9000 × g in Sorvall OTD-75 Ultra-
entrifuge (DuPont, Wilmington, USA), using the AH-629 (36 ml)
winging rotor, at 4 ◦C for a ﬁrst clearance. The supernatant, con-
aining the virus particles, was collected and stored. The resulting
ellets were suspended in 320 ml  of lyses buffer and centrifuged
gain under the above conditions for the enrichment of virus
xtraction. The supernatants were combined and added of 0.25%
f UltraPureTM SDS (Invitrogen, Carlsbad, USA) and 0.01% trypsin
:250 (Sigma–Aldrich, St. Louis, USA)/Milli-Q autoclaved water. The
nal volume was incubated along 2 h at 37 ◦C in a shaker, under
otation of 175 × g. After incubation, the material was centrifuged
or 1 h at 100,000 × g in a Sorvall AH-629 (36 ml)  swinging rotor
t 4 ◦C, discarding the supernatant. The pellet¸ consisting mainly
f collagen ﬁbers, was suspended in 2 mg/ml  collagenase solution
n lyses buffer, resulting in a ﬁnal volume of 5 ml.  The suspension
as incubated for four hours at 37 ◦C in a shaker, under rotation of
75 g.
The suspension was centrifuged for 1 h at 100,000 × g in Sorvall
H-650 swinging rotor in cellulose nitrate tubes of 5 ml,  discarding
he supernatant. The pellet was suspended in 400 l suspension
uffer (0.05 M NaCl, 0.01 M EDTA, 0.05 M PBS pH 7.4), which was
ransferred to cellulose nitrate tubes of 5 ml,  containing 4 ml  of
 solution of CsCl (density of 1.3 g/ml) in suspension buffer. The
ubes were centrifuged along 24 h at 136,000 × g in Sorvall AH-650
36 ml)  swinging rotor. After ultracentrifugation, the BPV virions
ere collected by aspiration and transferred to cryogenic tubes that
ad their volume completed to 2 ml  of PBS (137 mM NaCl, 2.7 mM
Cl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and stored at −80 ◦C.An aliquot of 500 l of isolated virions was destined to elec-
ronic transmission microscopy, being ﬁxed in glutaraldehyde
uffer at 2%, dehydrated in ethanol, submitted to negative stainingt is able to amplify BPVs genra Deltapapillomavirus (BPV-1 and 2) and Epsilonpapil-
nre Xipapillomavirus (BPV-3, 4 and 6).
and included in epoxy resin. The material was  analyzed in elec-
tronic transmission microscopy Leo 906E (Carls Zeiss, Oberkochen,
Germany) and the images were captured by Mega View III cam-
era and using the software ITEM version E 23082007 (Olympus
Soft Imaging Solutions, Hamburg, Germany), employing a voltage
of 80 kV and a constant current of 1 A and a total magniﬁcation of
60,000–120,000×.
The Delta-Epsilon and Xi primers showed speciﬁcity for the dif-
ferent BPVs genera, according to Fig. 1. Using these primers, it was
possible to identify the presence of BPV-2 in 81.82% of samples
(63/77), being the most prevalent virus type. It was detected the
presence of BPV-5 in 11.68% of samples (9/77), BPV-9 in 3.89%
(3/77). The results also point out the presence of BPV-3 and the
putative virus type BR/UEL-2 in one sample each, being the ﬁrst
description of this putative virus type in São Paulo State, Brazil. It
was also observed the co-infection for more than one virus type in
ﬁve animals, representing 18.51% of analyzed animals.
Using the novel methodology proposed in this present work,
it was successfully achieved the isolation of complete BPV-2 viri-
ons. Although the molecular typifying had showed the presence of
four different types of BPV (BPV-2, 3, 5 and 9) and a putative new
type (BR/UEL-2), we only isolated BPV-2, the most frequent type
observed.
To conﬁrm the isolated virus, the material was submitted to
electronic transmission microscopy in a maximum magniﬁcation
of 120,000×, revealing the efﬁcacy of the novel methodology, indi-
cating the presence of high amount of BPV-2, with 55 nm diameter
particles, as expected (Fig. 2).
The isolated particles of BPV-2 were stocked at −80 ◦C. The novel
methodology proposed can be applied with equal success for isola-
tion of another BPVs types as well as for the Human Papillomavirus
(HPV), since the methodology allows isolating the virus in accor-
dance with the molecular weight.
A high frequency of bovine cutaneous papillomatosis was
observed in the studied population, especially among young ani-
mals aged between two  and three years. Similar results in animals
of the Simmental breed were observed by Turk et al. (2005). The
high incidence of papillomatosis is related to the densiﬁcation of
animals, since conﬁned populations are more susceptible to out-Only in Brazil, which has the second highest effective cattle herd
in the world, with approximately 210 million of animals, about
60% of the herd is infected by BPV (Stocco dos Santos et al., 1998).
122 R.P. Araldi et al. / Journal of Virological Methods 208 (2014) 119–124
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sig. 2. Isolated BPV2 particles from cutaneous papillomas using the proposed me
20,000×  (D).
his amount may  be even higher because the virus infection can be
symptomatic (Araldi et al., 2013), leading to the need of prophy-
actic and/or therapeutic vaccines.
The viral typing by sequencing requires the use of primers that
llow efﬁcient identiﬁcation of viral sequences. Accordingly, the
rimer set Delta-Epsilon and Xi were highly efﬁcient in identifying
equences of BPV in accordance with the virus genera. The Delta-
psilon primer was already described with the name of subAup
Maeda et al., 2007). However the cycling changes allowed its use
o detect BPVs of Delta and Epsilonpapillomavirus genres. In relation
o the Xi primer, this was the ﬁrst time that it was used and allowed
he successful identiﬁcation of Xipapillomavirus.
Viral typing was performed by sequencing, revealing the pres-
nce of BPV-2 in 81.81% (63/77) of samples, being the most
revalent virus type in the studied population, followed by the
PV-5, observed in 11.68% (9/77), BPV-9, detected in 3.89% (3/77)
nd BPV-3, observed in only one sample. It was also detected the
resence of supposed new viral type BR/UEL-2 in one sample.
The BR/UEL-2 was ﬁrstly identiﬁed in State of Paraná, being
bserved in skin papilloma of the axilla region (Claus et al., 2009).
he virus presents an identity matrix of 78% with the BPV-4, allow-
ng its classiﬁcation as a Xipapillomavirus (Claus et al., 2009).
We detected the BR/UEL-2 in a cutaneous papilloma in the tho-
acic region of a female animal. This ﬁnding points out to the BPV
istribution and dissemination for different areas, justifying the
eed for investment in larger epidemiological studies to under-
tand the different viral types circulating in Brazil and worldwide.logy in four different magniﬁcations: 16,000× (A), 36,000× (B), 75,000× (C) and
Currently, different virus types and putative new types of BPV have
been identiﬁed in Brazil (Lindsey et al., 2009; Melo et al., 2014;
Araldi et al., 2014).
It was observed co-infection in ﬁve animals. Although few stud-
ies have reported the co-infection, similar results were observed by
Lindsey et al. (2009), Araldi et al. (2013) and Carvalho et al. (2013).
The infection with more than one virus type demands investments
in vaccines with a broad spectrum of coverage, particularly related
to the most prevalent BPVs types (Nicholls and Stanley, 2000).
Since the development of ultracentrifugation technique, this
has frequently been used for virus isolation of Papillomavirus viri-
ons with gradient of cesium chloride (CsCl), plus a cushion of 40%
sucrose (Bujard, 1967; Favre, 1975; Baker et al., 1991; Vanslyke
et al., 1993; Zhou et al., 1995).
The ultracentrifugation promotes a compression of solutions,
resulting in a continuous increase of density of solutions in the
direction of centrifugal force (Meselson et al., 1957). This condi-
tion allows the isolation of BPV virions, with a buoyant density
of 1.34 g/ml of CsCl and empty particles (composed only by cap-
sids without genetic material) with a buoyant density of 1.29 g/ml
(Lancaster and Olson, 1982).
However, some problems were commonly observed in previ-
ous studies involving the BPV isolation, such as the difﬁculty to
concentrate the virions pellet (Karger et al., 1998; Wang et al.,
2007), obtaining the gradient of centrifugation and the disruption
of capsid due the multiple steps of ultracentrifugation, reducing the
number of isolated particles (Favre, 1975; Wang and Roden, 2013).
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The use of this novel method, results of adaptation of those
escribed previously in the literature, allowed the isolation of BPV-
 satisfactorily. We did not obtain enough samples, in terms of
eight, of other types identiﬁed in this study (BPV-3, 5, 9 and
R/UEL2), as the isolation technique requires at least 40 g of papil-
oma infected with only one virus type.
The results of electronic transmission microscopy revealed the
fﬁcacy of the novel methodology to BPV isolation, indicating a
igh number of viral particles, with approximately 55 nm,  which
orresponds to the diameter of BPV (Fig. 2).
The method presented in this work showed to be less laborious
han that reported in previous studies that employed the use of CsCl
radient plus a cushion of sucrose, while that proved effective in
he isolation of BPV virions. Another advantage obtained from the
se of this method was  to obtain a single band, comprising whole
irus BPV particles, without forming a second band composed of
NA without viral capsids. The formation of this second band rep-
esented one of the difﬁculties reported in the literature, because
t reduces the number of virions isolated (Favre, 1975).
Other change was the replacement of the sarcosil, an ionic sur-
actant derived from sarcosine by sodium dodecyl sulfate (SDS).
he replacement was done in view of their similar properties and
heir relatively close molecular weights, being 293.38 g/mol of the
arcosil and 288.38 g/mol of the SDS. Thus, the SDS is very common
eagent and its use allowed the BPV isolation.
The method proposed in this present work can be used with
qual success for isolation of another papillomaviruses, including
he HPV. Under this view, the isolation of speciﬁc types of BPV is
ritical to immune challenge, allowing the validation of vaccine
roducts through in vivo assays and the guarantee of the immuno-
enic efﬁcacy of candidate products to entrance into a market.
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